Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ESPR | Esperion Therapeutics, Inc. | Chief Financial Officer | $103K | Mar 14, 2022 | ||
MBX | MBX Biosciences, Inc. | Chief Financial Officer | Sep 12, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|